Immunocore Holdings (IMCR) Amortizatization of Intangibles (2023 - 2026)
Immunocore Holdings' (IMCR) quarterly Amortizatization of Intangibles came in at $627000.0 in Q1 2026, up 14.84% year-on-year from $546000.0 in Q1 2025, and down 6.0% quarter-over-quarter from $667000.0 in Q4 2025.
Immunocore Holdings (IMCR) Amortizatization of Intangibles (2023 - 2026) Analysis & Trends
Immunocore Holdings has disclosed Amortizatization of Intangibles across 4 years of filings, most recently posting $627000.0 for Q1 2026.
- Amortizatization of Intangibles for Q1 2026 came in at $627000.0, up 14.84% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.4 million (up 19.89% YoY), and the FY2025 annual result was $2.3 million, up 22.8% from the prior year.
- Amortizatization of Intangibles came in at $627000.0 for Q1 2026 at Immunocore Holdings, down from $667000.0 in the prior quarter.
- In the past five years, Amortizatization of Intangibles ranged from a high of $667000.0 in Q4 2025 to a low of $401000.0 in Q2 2023.
- The 4-year median for Amortizatization of Intangibles is $488000.0 (2024), against an average of $502615.4.
- Across the five-year window, Amortizatization of Intangibles advanced 6.14% in 2024 and soared 31.48% in 2025, its largest moves.
- Immunocore Holdings' Amortizatization of Intangibles stood at $437000.0 in 2023, then grew by 28.15% to $560000.0 in 2024, then rose by 19.11% to $667000.0 in 2025, then declined by 6.0% to $627000.0 in 2026.
- The last three Amortizatization of Intangibles figures came in at $627000.0 (Q1 2026), $667000.0 (Q4 2025), and $567000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amort. of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 767,934.24 Bn | 767,934.20 Bn | - | - |
| 2 | Belite Bio | 55,234.00 Bn | 55,234.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,823.14 Bn | 17,823.14 Bn | - | 13,267.00 |
| 4 | Legend Biotech | 3,624.50 Bn | 3,624.21 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,745.73 Bn | 1,745.73 Bn | - | - |
| 6 | Evaxion A | 1,540.85 Bn | 1,540.84 Bn | - | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.57 Bn | 105.33 Bn | 2.59 Bn | - |
| 9 | Abivax | 93.46 Bn | 93.46 Bn | - | - |
| 10 | Immunocore Holdings | 1.46 Bn | 616.35 Mn | 106.24 Mn | 627,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 627,000.00 |
| Mar 31, 2026 | 627,000.00 |
| Dec 31, 2025 | 667,000.00 |
| Dec 31, 2025 | 667,000.00 |
| Sep 30, 2025 | 567,000.00 |
| Sep 30, 2025 | 567,000.00 |
| Jun 30, 2025 | 568,000.00 |
| Jun 30, 2025 | 568,000.00 |
| Mar 31, 2025 | 546,000.00 |
| Mar 31, 2025 | 546,000.00 |
| Dec 31, 2024 | 560,000.00 |
| Dec 31, 2024 | 560,000.00 |
| Sep 30, 2024 | 488,000.00 |
| Sep 30, 2024 | 488,000.00 |
| Jun 30, 2024 | 432,000.00 |
| Jun 30, 2024 | 432,000.00 |
| Mar 31, 2024 | 432,000.00 |
| Mar 31, 2024 | 432,000.00 |
| Dec 31, 2023 | 437,000.00 |
| Dec 31, 2023 | 437,000.00 |